APM

Aptorum

1APM
GBR
NASDAQ

$4.63

24H

15.46%

Market Cap

25.3 M

Volume

22.8 K

Supply

5.5 M

Price Chart

About Aptorum - APM

Aptorum Group Limited is a biopharmaceutical company focused on the development and commercialization of a range of therapeutic and diagnostic technologies to address unmet medical needs. The company operates mainly in the discovery and development of drugs for the treatment of diseases in the areas of oncology, infectious diseases, and metabolic diseases.

What are Aptorum's core values and mission statement?

Aptorum Group Limited's mission is to discover and develop therapeutic assets for the betterment of human health, particularly by focusing on orphan diseases and unmet medical needs. The company's core values emphasize innovation, dedication to scientific excellence, and the commitment to positively impact patient communities through their medical solutions.

Who founded Aptorum and when?

Aptorum Group Limited was founded by Ian Huen in 2010.

Who leads Aptorum?

Aptorum Group Limited is led by its founder and Chief Executive Officer, Darren Lui.

Where is Aptorum located, and what is its base country?

Aptorum Group Limited is based in Hong Kong.

On which exchanges is Aptorum traded?

Aptorum Group Limited is traded on the Nasdaq Stock Market under the ticker symbol APM.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open/Close
Low/High
Volume
Cap

Aptorum (APM) Price Live Data

The live price of Aptorum (APM) is $4.63, with a trading volume of 22,793 in the last 24 hours. Wrapstocks updates the APM price in real-time. Aptorum is up 15.46% in the last 24 hours. The company has a live market cap of $25,331,194.00 and a supply of 5,471,100 APM stocks.

Aptorum (APM) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 15 hours and 56 minutes.

Exchange
NASDAQ
NASDAQ
NASDAQ Stock Exchange
USA
Opens in
15 hours and 56 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0
Last Updated
24 May 2024 07:56 PM